Stock Taper Q4 Sales: $211 million, up 17% year-over-year; pro forma sales (excluding CFP divestiture) increased 29%.
Full Year Sales: $839 million, a 4% increase; pro forma growth of 6%.
Gross Margin: Expanded to 33.6% in Q4, up 350 basis points; full year gross margin at 32.3%, up 100 basis points.
Adjusted EBITDA Margin: 20.1% in Q4, up 270 basis points; full year EBITDA margin remained flat at 19.2%.
Diluted EPS: $0.58 for Q4 (up 400% YoY); diluted non-GAAP EPS at $0.81 (up 145%).
Cash Flow: Record cash generation of $46 million in Q4, totaling $127 million for the year; second consecutive year of record free cash flow.
Debt Management: Paid down $82 million in debt, achieving a net debt to EBITDA ratio of 1.8, the lowest since 2022.
Turnaround Year: 2025 marked a return to growth after three years of declines, driven by effective go-to-market strategies and product innovation.
Product Launches: Significant new product introductions planned for 2026, with a focus on high-value, mission-critical solutions.
Portfolio Optimization: Divestiture of the CFP business to refocus on core competencies in hydraulics and electronics.
Leadership Changes: Strengthened executive team with key promotions to enhance operational execution and strategic focus.
Shareholder Returns: Initiated a share repurchase program and continued a 116-quarter streak of cash dividends.
Q1 2026 Sales Guidance: Expected between $218 million and $223 million, representing a 22% increase YoY on a pro forma basis.
2026 Full Year Sales Guidance: Projected between $820 million and $860 million, implying 6% growth at the midpoint.
Adjusted EBITDA Margin for 2026: Expected between 19.5% and 21%, reflecting continued margin expansion.
Diluted Non-GAAP EPS for 2026: Anticipated in the range of $2.60 to $2.90, representing 7% growth at the midpoint.
Macroeconomic Headwinds: Ongoing geopolitical uncertainties, global tariffs, and a weak consumer market could impact future performance.
Market Recovery Uncertainty: While some indicators show improvement, the recovery is characterized as slow and uneven, with potential risks from supply chain constraints, particularly in electronics.
Cautious Outlook for H2 2026: The company is guiding conservatively for the second half of 2026 due to tough comparables and uncertainty in order volumes.
Market Dynamics: Management acknowledged that while they are seeing order growth, the end markets remain volatile, particularly in agriculture and electronics.
Capital Allocation Strategy: Focus on debt reduction and increased CapEx for productivity enhancements, while managing headcount carefully in response to market conditions.
Visibility into Orders: The company highlighted that over half of Hydraulics sales go through distribution, which limits visibility into future orders compared to OEMs.
Channel Inventory Levels: Improvements in distributor inventory levels were noted, indicating a healthier supply chain, but overall end-market demand remains subdued. Overall, Helios Technologies demonstrated a strong recovery in 2025 with significant sales growth and improved profitability, while navigating various macroeconomic challenges. The outlook for 2026 remains cautiously optimistic, with a focus on sustaining growth and operational excellence.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT